Parallel Advisors, LLC Novo Cure LTD Transaction History

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,594 shares of NVCR stock, worth $17,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,594

Previous 1,918 16.89%

Holding current value

$17,486

Previous $34,000 17.65%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	SELL	$15.37 - $19.4 $4,979 - $6,285	-324 Reduced 16.89%	1,594 $28,000
Q1 2025 Apr 07, 2025	BUY	$17.82 - $30.19 $1,782 - $3,019	100 Added 5.5%	1,918 $34,000
Q4 2024 Feb 10, 2025	BUY	$14.54 - $33.41 $392 - $902	27 Added 1.51%	1,818 $54,000
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $1,123 - $1,680	-72 Reduced 3.86%	1,791 $27,000
Q2 2024 Aug 08, 2024	BUY	$11.83 - $24.05 $5,761 - $11,712	487 Added 35.39%	1,863 $31,000
Q1 2024 May 06, 2024	BUY	$12.42 - $17.29 $13,773 - $19,174	1,109 Added 415.36%	1,376 $21,000
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $311 - $441	28 Added 11.72%	267 $3,000
Q3 2023 May 20, 2024	BUY	$16.15 - $42.35 $3,601 - $9,444	223 Added 1393.75%	239 $3,000
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $3,601 - $9,444	223 Added 1393.75%	239 $3,000
Q2 2023 May 20, 2024	SELL	$40.29 - $82.51 $5,962 - $12,211	-148 Reduced 90.24%	16 $0
Q2 2023 Aug 04, 2023	SELL	$40.29 - $82.51 $5,962 - $12,211	-148 Reduced 90.24%	16 $0
Q1 2023 May 20, 2024	SELL	$56.44 - $118.81 $68,405 - $143,997	-1,212 Reduced 88.08%	164 $9,000
Q1 2023 Apr 25, 2023	SELL	$56.44 - $118.81 $19,528 - $41,108	-346 Reduced 67.84%	164 $9,000
Q4 2022 Feb 03, 2023	BUY	$63.98 - $85.37 $1,535 - $2,048	24 Added 4.94%	510 $37,000
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $4,487 - $5,911	-66 Reduced 11.96%	486 $37,000
Q2 2022 Aug 01, 2022	SELL	$56.6 - $89.9 $6,848 - $10,877	-121 Reduced 17.98%	552 $38,000
Q1 2022 Apr 28, 2022	BUY	$60.15 - $84.52 $13,593 - $19,101	226 Added 50.56%	673 $57,000
Q4 2021 Jan 20, 2022	BUY	$75.08 - $121.99 $22,073 - $35,865	294 Added 192.16%	447 $34,000
Q3 2021 Nov 02, 2021	SELL	$116.17 - $194.55 $697 - $1,167	-6 Reduced 3.77%	153 $18,000
Q2 2021 Aug 06, 2021	BUY	$130.4 - $225.58 $11,866 - $20,527	91 Added 133.82%	159 $35,000
Q1 2021 Apr 23, 2021	BUY	$124.11 - $190.17 $1,985 - $3,042	16 Added 30.77%	68 $9,000
Q4 2020 Feb 02, 2021	BUY	$112.16 - $174.14 $5,832 - $9,055	52 New	52 $9,000
Q2 2020 Jul 16, 2020	SELL	$57.2 - $74.41 $171 - $223	-3 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$57.05 - $95.75 $171 - $287	3 New	3 $0

Others Institutions Holding NVCR

# of Institutions

260

Shares Held

79.3M

Call Options Held

970K

Put Options Held

118K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.15B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Novo Cure LTD Transaction History